DURHAM, N.C. (WNCN) — A Durham man with stage four lung cancer credits a Duke clinical trial for giving him his life back.

Medically reviewed by Brian Bezack, DOMedically reviewed by Brian Bezack, DO Stage 3 lung cancer is considered ... greater risk of recurrence Considered inoperable and are primarily treated ...

AstraZeneca’s hopes of positioning its PD-L1 inhibitor Imfinzi as a post-surgery therapy for people with earlier-stage lung ... inoperable or unresected stage I-II NSCLC in PACIFIC-4 and ...